Tevogen Bio Holdings (TVGN)

• Market cap: $80.2M
• 1 day: -6.16%
• 5 days: -1.03%
• 1 month: -13.36%
• 3 months: -53.39%
• 6 months: -68.23%
• Year to date: -61.93%
• 1 year: -60.05%
• 5 years: -95.94%
• 10 years: -95.94%
• Sector: Healthcare
• Industry: Biotechnology

About: Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Employees: 17